US FDA Actions On Rx Drug Promos Covered New Territory Last Year

2020-2021 PINK SHEET PERSPECTIVES - Megaphone
FDA issued fewer Rx drug promo enforcement letters in 2020 while initiating six new research projects • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Marketing & Advertising

More from Compliance